本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Chemomab Therapeutics Ltd.

1.09
0.0000
盘后1.090.00000.00%19:46 EDT
成交量:14.66万
成交额:16.45万
市值:2,088.85万
市盈率:-1.64
高:1.20
开:1.17
低:1.09
收:1.09
数据加载中...
2025/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/29

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/21

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/04

SEC问询函

Form CORRESP - Correspondence
2024/08/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/03/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/02

SEC问询函

Form CORRESP - Correspondence
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/05

重要事件披露

Form 8-K - Current report
2023/05/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/03/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/20

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933